Publications by authors named "Cervetti Giulia"

Claim this Profile
T
Therapeutic approach to patients with early stage diffuse large B cell lymphoma: retrospective, multicenter, real-life study of the 'RTL' (regional Tuscan lymphoma network).
Emanuele Cencini, Marianna Palazzo, Dimitri Dardanis, Giulia Lucco Navei, Lara Mannelli, Giulia Cervetti

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Giulia Lucco Navei, Giulia Cervetti

Ann Hematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease.
Edoardo Benedetti, Claudia Baratè, Fabrizio Mavilia, Emilia Bramanti, Riccardo Morganti, Giulia Cervetti

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy.
Edoardo Benedetti, Fabrizio Mavilia, Claudia Baratè, Emilia Bramanti, Riccardo Morganti, Giulia Cervetti

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia.
Francesco Mazziotta, Nadia Cecconi, Lorenzo Iovino, Giulia Cervetti, Mario Petrini

Cureus· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia.
Francesca Martini, Nadia Cecconi, Aldo Paolicchi, Sara Galimberti, Giulia Cervetti

TH Open· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
Sara Galimberti, Elena Ciabatti, Giacomo Ercolano, Susanna Grassi, Francesca Guerrini, Giulia Cervetti

Front Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.
Giulia Cervetti, Francesco Ghio, Nadia Cecconi, Riccardo Morganti, Sara Galimberti

J Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
Laura Galeotti, Francesco Ceccherini, Dario Domingo, Marco Laurino, Marialuisa Polillo, Giulia Cervetti, Giulia Fontanelli

Cancer Chemother Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of V600E Mutation in Hairy Cell Leukemia.
Francesca Guerrini, Matteo Paolicchi, Francesco Ghio, Elena Ciabatti, Susanna Grassi, Giulia Cervetti

Front Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
Giovanni Carulli, Claudia Baratè, Alessandra Marini, Virginia Ottaviano, Giulia Cervetti, Giulia Fontanelli

Hematol Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments.
Luca Laurenti, Idanna Innocenti, Francesco Autore, Barbara Vannata, Dimitar G Efremov, Giulia Cervetti

Leuk Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Primary Non-Hodgkin's Lymphoma of the External Auditory Canal.
Luca Bruschini, Andrea De Vito, Susanna Fortunato, Marco Pelosini, Giulia Cervetti

Case Rep Otolaryngol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus doxorubicin and dexamethasone as induction therapy in previously untreated multiple myeloma patients.
Gabriele Buda, Enrico Orciuolo, Giovanni Carulli, Sara Galimberti, Francesco Ghio, Giulia Cervetti

Acta Haematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institution.
Antonio Azzarà, Giovanni Carulli, Sara Galimberti, Claudia Baratè, Rita Fazzi, Giulia Cervetti

Am J Hematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib.
Giovanni Carulli, Elisa Cannizzo, Virginia Ottaviano, Giulia Cervetti, Gabriele Buda

Leuk Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Fabio Galetta, Ferdinando Franzoni, Giulia Cervetti, Francesco Regoli, Poupak Fallahi

Biomed Pharmacother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype.
Sara Galimberti, Maria I Ferreri, Paolo Simi, Antonio Azzarà, Claudia Baratè, Giulia Cervetti

Br J Haematol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Massimo Federico, Stefano Luminari, Emilio Iannitto, Giuseppe Polimeno, Luigi Marcheselli, Giulia Cervetti

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
Giulia Cervetti, Sara Galimberti, Francesca Andreazzoli, Rita Fazzi, Nadia Cecconi

Br J Haematol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex translocation t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index in chronic myeloid leukaemia.
Enrico Orciuolo, Gabriele Buda, Sara Galimberti, Giulia Cervetti, Nadia Cecconi

Leuk Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
Giulia Cervetti, Giovanni Carulli, Sara Galimberti, Antonio Azzarà, Gabriele Buda

Leuk Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
Enrico Orciuolo, Gabriele Buda, Sara Galimberti, Elisabetta Sordi, Giulia Cervetti

Cancer Genet Cytogenet· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected cardiotoxicity in haematological bortezomib treated patients.
Orciuolo Enrico, Buda Gabriele, Cecconi Nadia, Galimberti Sara, Versari Daniele, Cervetti Giulia

Br J Haematol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Ph-negative abnormal clones emerging during imatinib therapy.
Elisabetta Abruzzese, Alessandro Gozzetti, Sara Galimberti, Malgorzata Monika Trawinska, Tommaso Caravita, Giulia Cervetti

Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis